Inducible nitric oxide synthase links NF-κB to PGE2 in polyunsaturated fatty acid altered fibroblast in-vitro wound healing

Lipids in Health and Disease

Volumn 4, Issue , 2005, Pages

  Jia, Yi ^a   Turek, John J ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; ICOSAPENTAENOIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; POLYUNSATURATED FATTY ACID; PROSTAGLANDIN E2;

ANIMAL CELL; ARTICLE; BIOACCUMULATION; COLLAGEN SYNTHESIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; FIBROBLAST; IN VITRO STUDY; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN FUNCTION; WOUND HEALING;

ANIMALS; ARACHIDONIC ACID; COLLAGEN; DINOPROSTONE; EICOSAPENTAENOIC ACID; FATTY ACIDS, UNSATURATED; MICE; MODELS, BIOLOGICAL; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; NITRITES; POLYMERASE CHAIN REACTION; SWISS 3T3 CELLS; WOUND HEALING;

EID: 84872278448     PISSN: 1476511X     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-4-14     Document Type: Article

References (43)

1. Hill C, Flyvbjerg A, Rasch R, Bak M, Logan A: Transforming growth factor-beta2 antibody attenuates fibrosis in the experimental diabetic rat kidney. J Endocrinol 2001, 170:647-651.
2. Ghosh AK: Factors involved in the regulation of type I collagen gene expression: implication in fibrosis. Exp Biol Med (Maywood ) 2002, 227:301-314 [http://www.ebmonline.org/cgi/content/abstract/227/5/301].
3. Kanzler S, Baumann M, Schirmacher P, Dries V, Bayer E, Gerken G, Dienes HP, Lohse AW: Prediction of progressive liver fibrosis in hepatitis C infection by serum and tissue levels of transforming growth factor-beta. J Viral Hepat 2001, 8:430-437.
4. Witte MB, Thornton FJ, Efron DT, Barbul A: Enhancement of fibroblast collagen synthesis by nitric oxide. Nitric Oxide 2000, 4:572-582.
5. Jia Y, Turek JJ: Polyenoic fatty acid ratios alter fibroblast collagen production via PGE2 and PGE receptor subtype response. Exp Biol Med (Maywood ) 2004, 229:676-683.
6. Molloy T, Wang Y, Murrell G: The roles of growth factors in tendon and ligament healing. Sports Med 2003, 33:381-394.
7. Daniels JT, Cambrey AD, Occleston NL, Garrett Q, Tarnuzzer RW, Schultz GS, Khaw PT: Matrix metalloproteinase inhibition modulates fibroblast-mediated matrix contraction and collagen production in vitro. Invest Ophthalmol Vis Sci 2003, 44:1104-1110.
8. Watkins BA, Xu H, Turek JJ: Linoleate impairs collagen synthesis in primary cultures of avian chondrocytes. Proc Soc Exp Biol Med 1996, 212:153-159.
9. Hankenson KD, Watkins BA, Schoenlein IA, Allen KG, Turek JJ: Omega-3 fatty acids enhance ligament fibroblast collagen formation in association with changes in interleukin-6 production. Experimental Biology & Medicine 2000, 223:88-95.
10. Baldwin AS: The NF-kappa B and Ikappa B proteins: new discoveries and insights. Annual Review of Immunology 1996, 14:649-681.
11. Jia Y, Turek JJ: Altered NF-kappaB gene expression and collagen formation induced by polyunsaturated fatty acids. Journal of Nutritional Biochemistry 2005.
12. Xie QW, Kashiwabara Y, Nathan C: Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. J Biol Chem 1994, 269:4705-4708.
13. MR S, PA E, FJ T, K K, SS G, A B: Nitric oxide, an autocrine regulator of wound fibroblast synthetic function. J Immunol 1997, 158:2375-2381.
14. Witte MB, Barbul A: Role of nitric oxide in wound repair. Am J Surg 2002, 183:406-412 [http://www.sciencedirect.com/science/arti cle/B6VHS-45MCKV4-D/2/ 78ad2d77240787500bac01a116c23036].
15. Shi HP, Most D, Efron DT, Tantry U, Fischel MH, Barbul A: The role of iNOS in wound healing. Surgery 2001, 130:225-229.
16. Muscara MN, McKnight W, Asfaha S, Wallace JL: Wound collagen deposition in rats: effects of an NO-NSAID and a selective COX-2 inhibitor. Br J Pharmacol 2000, 129:681-686.
17. Cardoso CR, Souza MA, Ferro EA, Jr FS, Pena JD: Influence of topical administration of n-3 and n-6 essential and n-9 nonessential fatty acids on the healing of cutaneous wounds. Wound Repair Regen 2004, 12:235-243.
18. Albina JE, Gladden P, Walsh WR: Detrimental effects of an omega-3 fatty acid-enriched diet on wound healing. JPEN J Parenter Enteral Nutr 1993, 17:519-521.
19. Scardino MS, Swaim SF, Sartin EA, Hoffman CE, Oglivie GK, Hanson RA, Coolman SL, Davenport DJ: The effects of omega-3 fatty acid diet enrichment on wound healing. Veterinary Dermatology 1999, 10:283-290.
20. Gilmore MA: Phases of wound healing. Dimens Oncol Nurs 1991, 5:32-34.
21. Bowes LE, Jimenez MC, Hiester ED, Sacks MS, Brahmatewari J, Mertz P, Eaglstein WH: Collagen fiber orientation as quantified by small angle light scattering in wounds treated with transforming growth factor-beta2 and its neutalizing antibody. Wound Repair Regen 1999, 7:179-186.
22. Shimizu H, Mitomo K, Watanabe T, Okamoto S, Yamamoto K: Involvement of a NF-kappa B-like transcription factor in the activation of the interleukin-6 gene by inflammatory lymphokines. Mol Cell Biol 1990, 10:561-568.
23. Morris KR, Lutz RD, Choi HS, Kamitani T, Chmura K, Chan ED: Role of the NF-kappaB signaling pathway and kappaB cis-regulatory elements on the IRF-1 and iNOS promoter regions in mycobacterial lipoarabinomannan induction of nitric oxide. Infect Immun 2003, 71:1442-1452.
24. Coleman JW: Nitric oxide in immunity and inflammation. Int Immunopharmacol 2001, 1:1397-1406.
25. Knowles RG, Moncada S: Nitric oxide synthases in mammals. Biochem J 1994, 298 ( Pt 2):249-258.
26. Park SK, Lin HL, Murphy S: Nitric oxide regulates nitric oxide synthase-2 gene expression by inhibiting NF-kappaB binding to DNA. Biochem J 1997, 322 ( Pt 2):609-613.
27. Kleinert H, Euchenhofer C, Ihrig-Biedert I, Forstermann U: In murine 3T3 fibroblasts, different second messenger pathways resulting in the induction of NO synthase II (iNOS) converge in the activation of transcription factor NF-kappaB. J Biol Chem 1996, 271:6039-6044.
28. Jones MK, Tsugawa K, Tarnawski AS, Baatar D: Dual actions of nitric oxide on angiogenesis: possible roles of PKC, ERK, and AP-1. Biochem Biophys Res Commun 2004, 318:520-528.
29. Clancy R, Varenika B, Huang W, Ballou L, Attur M, Amin AR, Abramson SB: Nitric oxide synthase/COX cross-talk: nitric oxide activates COX-1 but inhibits COX-2-derived prostaglandin production. J Immunol 2000, 165:1582-1587.
30. Clancy R, Varenika B, Huang W, Ballou L, Attur M, Amin AR, Abramson SB: Nitric Oxide Synthase/COX Cross-Talk: Nitric Oxide Activates COX-1 But Inhibits COX-2-Derived Prostaglandin Production. The Journal of Immunology 2000, 165:1582-1587.
31. az-Cazorla M, Perez-Sala D, Lamas S: Dual effect of nitric oxide donors on cyclooxygenase-2 expression in human mesangial cells. J Am Soc Nephrol 1999, 10:943-952.
32. Patel R, Attur MG, Dave M, Abramson SB, Amin AR: Regulation of cytosolic COX-2 and prostaglandin E2 production by nitric oxide in activated murine macrophages. J Immunol 1999, 162:4191-4197.
33. Rhee SH, Hwang D: Murine TOLL-like receptor 4 confers lipopolysaccharide responsiveness as determined by activation of NF kappa B and expression of the inducible cyclooxygenase. J Biol Chem 2000, 275:34035-34040.
34. Varga J, Diaz-Perez A, Rosenbloom J, Jimenez SA: PGE2 causes a coordinate decrease in the steady state levels of fibronectin and types I and III procollagen mRNAs in normal human dermal fibroblasts. Biochem Biophys Res Commun 1987, 147:1282-1288.
35. FB R, WF L, JR B, LF S, G K, MB G: Suppression of type I collagen gene expression by prostaglandins in fibroblasts is mediated at the transcriptional level. Mol Med 2000, 6:705-719.
36. Ferrini MG, Vernet D, Magee TR, Shahed A, Qian A, Rajfer J, Gonzalez-Cadavid NF: Antifibrotic role of inducible nitric oxide synthase. Nitric Oxide 2002, 6:283-294.
37. D. C, K.S.N. K: Induction of cell proliferation and collagen synthesis in human small intestinal lamina propria fibroblasts by lipopolysaccharide: possible involvement of nitric oxide. Biochemical and Biophysical Research Communications 1997, 240:458-463.
38. Thornton FJ, Schaffer MR, Witte MB, Moldawer LL, MacKay SL, Abouhamze A, Tannahill CL, Barbul A: Enhanced collagen accumulation following direct transfection of the inducible nitric oxide synthase gene in cutaneous wounds. Biochem Biophys Res Commun 1998, 246:654-659.
39. Schaffer MR, Tantry U, van Wesep RA, Barbul A: Nitric oxide metabolism in wounds. J Surg Res 1997, 71:25-31.
40. Stallmeyer B, Kampfer H, Kolb N, Pfeilschifter J, Frank S: The function of nitric oxide in wound repair: inhibition of inducible nitric oxide-synthase severely impairs wound reepithelialization. J Invest Dermatol 1999, 113:1090-1098.
41. Yamasaki K, Edington HD, McClosky C, Tzeng E, Lizonova A, Kovesdi I, Steed DL, Billiar TR: Reversal of impaired wound repair in iNOS-deficient mice by topical adenoviral-mediated iNOS gene transfer. J Clin Invest 1998, 101:967-971.
42. Du M, Islam MM, Lin L, Ohmura Y, Moriyama Y, Fujimura S: Promotion of proliferation of murine BALB/C3T3 fibroblasts mediated by nitric oxide at lower concentrations. Biochem Mol Biol Int 1997, 41:625-631.
43. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR: Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem 1982, 126:131-138.